156 related articles for article (PubMed ID: 29746508)
1. CUL5 is required for thalidomide-dependent inhibition of cellular proliferation.
Kunkler B; Salamango D; DeBruine ZJ; Ploch C; Dean S; Grossens D; Hledin MP; Marquez GA; Madden J; Schnell A; Short M; Burnatowska-Hledin MA
PLoS One; 2018; 13(5):e0196760. PubMed ID: 29746508
[TBL] [Abstract][Full Text] [Related]
2. Nuclear localization signal sequence is required for VACM-1/CUL5-dependent regulation of cellular growth.
Willis AN; Dean SE; Habbouche JA; Kempers BT; Ludwig ML; Sayfie AD; Lewis SP; Harrier S; DeBruine ZJ; Garrett R; Burnatowska-Hledin MA
Cell Tissue Res; 2017 Apr; 368(1):105-114. PubMed ID: 27834018
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of VACM-1/Cul5 by protein kinase A regulates its neddylation and antiproliferative effect.
Bradley SE; Johnson AE; Le IP; Oosterhouse E; Hledin MP; Marquez GA; Burnatowska-Hledin M
J Biol Chem; 2010 Feb; 285(7):4883-95. PubMed ID: 19917606
[TBL] [Abstract][Full Text] [Related]
4. Expression of VACM-1/cul5 mutant in endothelial cells induces MAPK phosphorylation and maspin degradation and converts cells to the angiogenic phenotype.
Buchwalter A; Van Dort C; Schultz S; Smith R; Le IP; Abbott JL; Oosterhouse E; Johnson AE; Hansen-Smith F; Burnatowska-Hledin M
Microvasc Res; 2008 Mar; 75(2):155-68. PubMed ID: 17950367
[TBL] [Abstract][Full Text] [Related]
5. VACM-1/cul5 expression in vascular tissue in vivo is induced by water deprivation and its expression in vitro regulates aquaporin-1 concentrations.
Johnson AE; Le IP; Andresen BT; Stodola J; Dewey GL; Dean SB; Resau J; Haak P; Ruch T; Sartor A; Lazdins I; Barney CC; Burnatowska-Hledin MA
Cell Tissue Res; 2012 Aug; 349(2):527-39. PubMed ID: 22581383
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol enhances anti-proliferative effect of VACM-1/cul5 in T47D cancer cells.
Lubbers J; Lewis S; Harper E; Hledin MP; Marquez GA; Johnson AE; Graves DR; Burnatowska-Hledin MA
Cell Biol Toxicol; 2011 Apr; 27(2):95-105. PubMed ID: 20949323
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase.
Liu B; Sarkis PT; Luo K; Yu Y; Yu XF
J Virol; 2005 Aug; 79(15):9579-87. PubMed ID: 16014920
[TBL] [Abstract][Full Text] [Related]
8. New insights into the mechanism for VACM-1/cul5 expression in vascular tissue in vivo.
Burnatowska-Hledin MA; Barney CC
Int Rev Cell Mol Biol; 2014; 313():79-101. PubMed ID: 25376490
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus E4orf6 assembles with Cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV/SIV Vif-like BC-box to regulate p53.
Luo K; Ehrlich E; Xiao Z; Zhang W; Ketner G; Yu XF
FASEB J; 2007 Jun; 21(8):1742-50. PubMed ID: 17351129
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of VACM-1/cul5 exons in cancer cell lines.
Lewis SP; Willis AN; Johnson AE; Resau J; Burnatowska-Hledin MA
APMIS; 2011 Jul; 119(7):421-30. PubMed ID: 21635549
[TBL] [Abstract][Full Text] [Related]
11. Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G.
Luo K; Xiao Z; Ehrlich E; Yu Y; Liu B; Zheng S; Yu XF
Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11444-9. PubMed ID: 16076960
[TBL] [Abstract][Full Text] [Related]
12. Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182.
Devor EJ; Schickling BM; Reyes HD; Warrier A; Lindsay B; Goodheart MJ; Santillan DA; Leslie KK
Oncol Rep; 2016 Apr; 35(4):2461-5. PubMed ID: 26847831
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of thalidomide by human liver microsome cytochrome CYP2C19 is required for its antimyeloma and antiangiogenic activities in vitro.
Li Y; Jiang Z; Xiao Y; Li L; Gao Y
Hematol Oncol; 2012 Mar; 30(1):13-21. PubMed ID: 21638302
[TBL] [Abstract][Full Text] [Related]
14. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.
Kamura T; Maenaka K; Kotoshiba S; Matsumoto M; Kohda D; Conaway RC; Conaway JW; Nakayama KI
Genes Dev; 2004 Dec; 18(24):3055-65. PubMed ID: 15601820
[TBL] [Abstract][Full Text] [Related]
15. Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif.
Xiao Z; Ehrlich E; Yu Y; Luo K; Wang T; Tian C; Yu XF
Virology; 2006 Jun; 349(2):290-9. PubMed ID: 16530799
[TBL] [Abstract][Full Text] [Related]
16. Using the E4orf6-Based E3 Ubiquitin Ligase as a Tool To Analyze the Evolution of Adenoviruses.
Gilson T; Blanchette P; Ballmann MZ; Papp T; Pénzes JJ; Benkő M; Harrach B; Branton PE
J Virol; 2016 Aug; 90(16):7350-7367. PubMed ID: 27252531
[TBL] [Abstract][Full Text] [Related]
17. A novel effect of thalidomide and its analogs: suppression of cereblon ubiquitination enhances ubiquitin ligase function.
Liu Y; Huang X; He X; Zhou Y; Jiang X; Chen-Kiang S; Jaffrey SR; Xu G
FASEB J; 2015 Dec; 29(12):4829-39. PubMed ID: 26231201
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.
Gu Q; Zhang Z; Gertzen CGW; Häussinger D; Gohlke H; Münk C
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263270
[TBL] [Abstract][Full Text] [Related]
19. ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection.
Hüttenhain R; Xu J; Burton LA; Gordon DE; Hultquist JF; Johnson JR; Satkamp L; Hiatt J; Rhee DY; Baek K; Crosby DC; Frankel AD; Marson A; Harper JW; Alpi AF; Schulman BA; Gross JD; Krogan NJ
Cell Host Microbe; 2019 Jul; 26(1):86-99.e7. PubMed ID: 31253590
[TBL] [Abstract][Full Text] [Related]
20. Both Rbx1 and Rbx2 exhibit a functional role in the HIV-1 Vif-Cullin5 E3 ligase complex in vitro.
Wang X; Wang X; Wang W; Zhang J; Wang J; Wang C; Lv M; Zuo T; Liu D; Zhang H; Wu J; Yu B; Kong W; Wu H; Yu X
Biochem Biophys Res Commun; 2015 Jun; 461(4):624-9. PubMed ID: 25912140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
